Literature DB >> 12046464

[Immunogenic and protective characteristics of recombinant Lassa virus NP protein].

G M Ignat'ev.   

Abstract

Recombinant fragment of Lassa virus (strain Josiah) nucleocapsid protein (corresponding to amino acid residues 141 + 569) constructed by Dr. Jan ter Meulen (Tropenmedizine, Hamburg) was used for immunizing CBA/calac mice. The preparation was injected intraperitoneally twice with 2-week interval in a dose of 10 micrograms. The parameters of the resultant specific humoral and cell-mediated immunity were comparable to those in reference animals immunized with inactivated Lassa virus. Challenge with Lassa virus (10,000 PFU) resulted in 100% death of the reference animals, while of 15 animals immunized with the recombinant NP protein 8 survived.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046464

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN: 0507-4088


  2 in total

1.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

2.  Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance.

Authors:  Luis M Branco; Alex Matschiner; Joseph N Fair; Augustine Goba; Darryl B Sampey; Philip J Ferro; Kathleen A Cashman; Randal J Schoepp; Robert B Tesh; Daniel G Bausch; Robert F Garry; Mary C Guttieri
Journal:  Virol J       Date:  2008-06-06       Impact factor: 4.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.